Nellix Inc.’s development of a tiny surgical device that supports blood flow through damaged arteries has attracted venture investment from two prestigious Bay Area based private equity groups, The Band of Angels and Incubic Venture Fund. This is the first institutional round in the early stage medical device startup, located in Redwood City. “This project has enormous potential to treat AAA percutaneously,” said Jim McKinley CEO of Nellix, “The Band of Angels and the Incubic Venture Fund are great partners for us, including the addition of Bill Nighan, partner at Incubic Venture Fund, and Dr. Wally Buch, Member of the Band of Angels, to our Board of Directors.
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 03/17/08 | Series C | 6.5M | Partner Capital, BroadPeak | Unknown |
People
Gwen Watanabe (President, CEO)
Guido Neels (Board Member)
Michael Gertner (President/CEO)
Wally Buch (Board Member)
William Nighan (Board Member)
News
Nellix takes $6M to treat aneurysms before they happen
October 13, 2009 4:00 pm
Nellix Endovascular, a Palo Alto, Calif.-based maker of devices used to repair damaged blood vessels that could lead to aneurysms,… Continue reading ⟩
Life-science briefing: Monday, March 17, 2008
March 17, 2008 8:01 am
TODAY’S HEADLINES: Defibrillator maker Cameron Health takes in $14M (VBLS exclusive) Miramar Labs gets $20M for “aesthetic” devices (VBLS exclusive)… Continue reading ⟩
Exclusive news on life-science start-up fundings: Cameron, Nellix, Miramar, Chestnut
March 15, 2008 9:55 pm
We’ve just posted a number of exclusive life-science fundings over at VentureBeat LifeScience. Click on the following links for news… Continue reading ⟩